.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Cipla
Accenture
Harvard Business School
US Army
Cerilliant
Queensland Health
Baxter
Argus Health
UBS

Generated: September 22, 2017

DrugPatentWatch Database Preview

Vansen Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for VANSEN PHARMA, and when can generic versions of VANSEN PHARMA drugs launch?

VANSEN PHARMA has one approved drug.

There is one US patent protecting VANSEN PHARMA drugs.

There are seventeen patent family members on VANSEN PHARMA drugs in fifteen countries.

Summary for Applicant: Vansen Pharma

Patents:1
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-001Aug 29, 2001DISCNNoNo► Subscribe► Subscribe ► Subscribe
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-002Jul 21, 2008DISCNNoNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Vansen Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-001Aug 29, 2001► Subscribe► Subscribe
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-002Jul 21, 2008► Subscribe► Subscribe
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-002Jul 21, 2008► Subscribe► Subscribe
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-001Aug 29, 2001► Subscribe► Subscribe
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-001Aug 29, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Vansen Pharma Drugs

Country Document Number Estimated Expiration
Mexico9802849► Subscribe
Hungary9900609► Subscribe
Canada2234426► Subscribe
Hong Kong1016477► Subscribe
Taiwan458778► Subscribe
European Patent Office0862915► Subscribe
Austria214930► Subscribe
Portugal862915► Subscribe
World Intellectual Property Organization (WIPO)9713516► Subscribe
China1202110► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Merck
US Department of Justice
Johnson and Johnson
Farmers Insurance
Dow
Fish and Richardson
Daiichi Sankyo
Deloitte
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot